TITLE

Mid-term results of cardiac autotransplantation as method to treat permanent atrial fibrillation and mitral disease

AUTHOR(S)
Troise, Giovanni; Cirillo, Marco; Brunelli, Federico; Tasca, Giordano; Amaducci, Andrea; Mhagna, Zen; Tomba, Margherita Dalla; Quaini, Eugenio
PUB. DATE
June 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Jun2004, Vol. 25 Issue 6, p1025
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: The results of current surgical options for the treatment of permanent atrial fibrillation (AF) associated with mitral surgery are widely different, particularly in very enlarged left atria. The aim of this study was to assess the mid-term efficacy of cardiac autotransplantation for this goal, through a consistent reduction of left atrium volume and a complete isolation of the pulmonary veins. Methods: From April 2000 to September 2002, 30 patients (male/female 5/25) underwent cardiac autotransplantation for the treatment of mitral valve disease and concomitant permanent AF (>1 year). Surgical technique of bicaval heart transplantation was modified maintaining the connection of inferior vena cava in all but three cases. Twenty-eight patients had mitral valve replacement and two had mitral valve repair. Associated procedures were: aortic valve replacement (6 cases), tricuspid valve repair (2 cases), coronary re-vascularization (2 cases) and right atrium volume reduction (4 cases). Results: No hospital death occurred; 1 patient died 3 months post-operatively for pneumonia. At a mean follow-up of 21.1±7.7 months (range 6–35), 26 patients (89.7%) were in sinus rhythm and 3 (10.3%) in AF. Santa Cruz Score was 0 in 3 patients, 2 in 2 patients and 4 in the remaining 24 patients (82.7%). Mean left atrial diameter and volume decreased from 65.1±16.4 mm (range 50–130 mm) to 49.9±8.4 mm (range 37–78) (P<0.001) and from 118.3±68.4 ml (range 60–426) to 69.4±34.1 ml (range 31–226) (P=0.001), respectively, after the operation. Conclusions: Cardiac autotransplantation is a safe and effective option for the treatment of permanent AF in patients with mitral valve disease and severe dilation of left atrium.
ACCESSION #
13115586

 

Related Articles

  • Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Hunt; Deng, Mario C; De Meester, Johan M J; Smits, Jacqueline M A; Heinecke, Joachim; Scheld, Hans H // BMJ: British Medical Journal (International Edition);09/02/2000, Vol. 321 Issue 7260, p540 

    Objective: To determine whether there is a survival benefit associated with cardiac transplantation in Germany.Design: Prospective observational cohort study.Setting: All 889 adult patients listed for a first heart transplant in Germany in 1997.Main outcome measure: Mortality, stratified by...

  • Current Status of Cardiac Transplantation and Left Ventricular Assist Devices. Frazier, O. H. // Texas Heart Institute Journal;2010, Vol. 37 Issue 3, p319 

    The article discusses the trend in cardiac transplantation and developments in left ventricular assist devices in the U.S. market as of June 2010. The first successful heart transplantation was reportedly performed in April 1968. The author shares that between 1982 and 1992, he performed 138...

  • Sympathetic reinnervation after heart transplantation, assessed by iodine-123 metaiodobenzylguanidine imaging, and heart rate variability Lovric, Silvia Samarin; Avbelj, Viktor; Trobec, Roman; Zorman, Darko; Rakovec, Peter; Hojker, Sergej; Gersak, Borut; Milcinski, Metka // European Journal of Cardio-Thoracic Surgery;Oct2004, Vol. 26 Issue 4, p736 

    Objective: Complete allograft denervation occurs during heart transplantation. Partial ventricular sympathetic reinnervation may develop one year or later after transplantation and can be measured with iodine-123-meta-iodobenziylguanidine (MIBG) uptake. Aim of this study was to assess sinus node...

  • Christiaan Barnard: his first transplants and their impact on concepts of death. Hoffenberg, Raymond // BMJ: British Medical Journal (International Edition);12/22/2001, Vol. 323 Issue 7327, p1478 

    Discusses the career of Christiaan Barnard, who performed the first human heart transplants in 1967. Reasons why these transplants were performed in Cape Town, South Africa, including the standard of medicine in Cape Town; Results of similar operations performed immediately after those by...

  • Legal Aspects of Human Organ Transplantation in Canada. CASTEL, J.-G. // Canadian Medical Association Journal;9/21/1968, Vol. 99 Issue 11, p533 

    The article discusses the legal issues associated with human organ transplantation in Canada. It provides a background on the significant developments in heart transplantation and other vital organs. It notes the moral and ethical problems with organ donation and transplantation. It outlines the...

  • Gastrointestinal Complications after Cardiac Transplantation: A Spectrum of Diseases. Cates, J.; Chavez, M.; Laks, H.; Drinkwater, D.; Stevenson, L.; Kobashigawa, J.; Saunders, K.; Abedin, M.; Roslyn, J. // American Journal of Gastroenterology;Apr1991, Vol. 86 Issue 4, p412 

    Cardiac transplantation has become an accepted treatment modality for end-stage cardiac failure. The gastrointestinal (GI) tract represents a potential source of posttransplant morbidity and mortality. To define the scope of this problem, records of all patients undergoing cardiac...

  • Reverse Ventricular Remodeling and Improved Ventricular Compliance After Heart Transplantation in Infants and Young Children. Farooqi, Kanwal; Lopez, Leo; Pass, Robert; Hsu, Daphne; Lamour, Jacqueline // Pediatric Cardiology;Aug2014, Vol. 35 Issue 6, p922 

    After heart transplantation (HT) in infants and young children, environmental and intrinsic factors may lead to changes in the geometry and compliance of the donor heart. Serial demographic, clinical, hemodynamic, and echocardiographic data were obtained from HT recipients younger than 4 years...

  • Differential indication for mechanical circulatory support following heart transplantation. Minev, P.; El-Banayosy, A.; Minami, K.; Körtke, H.; Kizner, L.; Körfer, R. // Intensive Care Medicine;Aug2001, Vol. 27 Issue 8, p1321 

    Purpose: We describe our experience with ventricular assist devices (VAD) in patients with cardiogenic shock refractory to pharmacological therapy and support using intraaortic balloon pump after cardiac transplantation. Patients: Between July 1987 and August 1997, 848 patients underwent cardiac...

  • Donor heart preservation: history and current status in terms of translational medicine. Minasian, S. M.; Galagudza, M. M.; Dmitriev, Yu. V.; Karpov, A. A.; Bobrova, E. A.; Krasichkov, A. S.; Grigoriev, E. B.; Vlasov, T. D. // Regional Haemodynamics & Microcirculation;2014, Vol. 13 Issue 3, p4 

    The preservation of donor heart is the important problem of the transplantation and cardiac surgery. Despite the progress made, the need for further research on this issue is substantial. This review highlights the latest progress in terms of donor heart preservation and provides a focus for the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics